Acceso a las Pruebas de Biomarcadores Press Releases
Tennessee Senate Passes Biomarker Testing Coverage Bill, Sending to Governor's Desk
NASHVILLE, Tenn. – The Tennessee Senate unanimously passed a bill to expand coverage of biomarker testing on Thursday, April 16, sending it to the desk of Gov. Bill Lee.
Senado estatal da un paso para garantizar que los pacientes con cáncer reciban el tratamiento adecuado más rápido
El Senado estatal aprobó un proyecto de ley que ampliaría el acceso a las pruebas de biomarcadores, un avance clave en la lucha contra el cáncer y otras enfermedades y un paso esencial para acceder a tratamientos de precisión.
Senate Committee Passes Biomarker Testing Coverage Bill
NASHVILLE, Tenn. – On Tuesday, April 7, Senate Bill 0435 to expand coverage of biomarker testing in Tennessee overcame a significant hurdle, passing the Senate Commerce and Labor Committee.
Tennessee House Passes Biomarker Testing Coverage Bill
NASHVILLE, Tenn. – On Monday, March 30, the Tennessee House unanimously passed House Bill 0484 that would expand coverage of biomarker testing for patients facing a variety of diseases includin
Cancer Advocates to Convene on Beacon Hill to Urge Lawmakers to Reduce Health Disparities
Cancer survivors and caregivers urge lawmakers to support legislation that will increase access to precision medicine through biomarker testing.
DozDefensores de la salud pública se unen para aplaudir al Senado e instan a la Asamblea y a la gobernadora Hochul a “rechazar el retroceso”
Hoy temprano, una coalición liderada por la Red de Acción contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN), formada por defensores de los pacientes, promotores legislativos, líderes de salud pública y sobrevivientes de cáncer preocupados, se reunió para aplaudir al Senado y pedir a la gobernadora Hochul y al liderazgo de la Asamblea que se unan al Senado para preservar el acceso de los beneficiarios de Medicaid a las pruebas de biomarcadores.
Cancer Advocates Celebrate as Governor Signs “Jill’s Law” for Biomarker Testing Coverage
JACKSON, Miss. – Cancer advocates are celebrating after Gov.
NYS Senate Rejects Medicaid Rollback of Biomarker Testing Coverage Criteria, Patient Advocates Urge Governor & Assembly to Follow Suit in Final Budget
The one-house budget proposals revealed a clear divide in the Legislature’s approach to the equitable treatment of disease. The New York State Senate flatly rejected the governor’s proposal to roll back Medicaid coverage criteria for biomarker testing, heeding the calls of cancer survivors, patient advocates and public health organizations, like the American Cancer Society Cancer Action Network (ACS CAN). The Assembly took a more mixed approach accepting parts of the Governor’s proposed language while rejecting others.